| Does pattern electroretinogram spatial tuning alteration in Parkinson's disease depend on motor disturbances or retinal dopaminergic loss? A Peppe, P Stanzione, M Pierantozzi, R Semprini, A Bassi, AM Santilli, ... Electroencephalography and clinical neurophysiology 106 (4), 374-382, 1998 | 78 | 1998 |
| Homotaurine induces measurable changes of short latency afferent inhibition in a group of mild cognitive impairment individuals A Martorana, F Di Lorenzo, G Manenti, R Semprini, G Koch Frontiers in aging neuroscience 6, 254, 2014 | 48 | 2014 |
| Age and stage dependency of P300 latency alterations in non-demented Parkinson's disease patients without therapy P Stanzione, R Semprini, M Pierantozzi, AM Santilli, L Fadda, R Traversa, ... Electroencephalography and Clinical Neurophysiology/Evoked Potentials …, 1998 | 48 | 1998 |
| An electrophysiological study of D2 dopaminergic actions in normal human retina: a tool in Parkinson's disease P Stanzione, R Traversa, M Pierantozzi, R Semprini, MG Marciani, ... Neuroscience letters 140 (1), 125-128, 1992 | 28 | 1992 |
| Increasing doses of l-sulpiride reveal dose-and spatial frequency-dependent effects of D2 selective blockade in the human electroretinogram P Stanzione, M Pierantozzi, R Semprini, M Tagliati, R Traversa, A Peppe, ... Vision research 35 (18), 2659-2664, 1995 | 27 | 1995 |
| Quantitative EEG changes in non‐demented Parkinson's disease patients before and during L‐dopa therapy P Stanzione, MG Marciani, M Maschio, MA Bassetti, F Spanedda, ... European Journal of Neurology 3 (4), 354-362, 1996 | 26 | 1996 |
| A mixed D1 and D2 antagonist does not replay pattern electroretinogram alterations observed with a selective D2 antagonist in normal humans: relationship with Parkinson's … P Stanzione, I Bodis-Wollner, M Pierantozzi, R Semprini, M Tagliati, ... Clinical neurophysiology 110 (1), 82-85, 1999 | 21 | 1999 |
| Apathy as marker of frail status R Semprini, A Lubrano, G Misaggi, A Martorana Journal of Aging Research 2012 (1), 436251, 2012 | 18 | 2012 |
| SEPs N30 amplitude in Parkinson's disease and in pharmacologically induced rigidity: relationship with the clinical status P Stanzione, R Traversa, M Pierantozzi, R Semprini, M Loberti, A Peppe, ... European Journal of Neurology 4 (1), 24-38, 1997 | 11 | 1997 |
| Diabetes mellitus contributes to higher cerebrospinal fluid tau levels selectively in Alzheimer's disease patients with the APOE4 genotype C Motta, M Assogna, CG Bonomi, AP Mascolo, V De Lucia, R Semprini, ... European journal of neurology 28 (12), 3965-3971, 2021 | 10 | 2021 |
| Kyphoplasty: a new opportunity for rehabilitation of neurologic disabilities S Masala, D Tropepi, R Fiori, R Semprini, A Martorana, F Massari, ... American journal of physical medicine & rehabilitation 83 (10), 810-812, 2004 | 10 | 2004 |
| Observational clinical and nerve conduction study on effects of a nutraceutical combination on painful diabetic distal symmetric sensory-motor neuropathy in patients with … R Semprini, A Martorana, M Ragonese, C Motta Minerva Medica 109 (5), 358-362, 2018 | 9 | 2018 |
| N30 wave amplitude of somatosensory evoked potentials from median nerve in Parkinson's disease: a pharmacological study. R Traversa, M Pierantozzi, R Semprini, M Loberti, MC Cicardi, A Bassi, ... Journal of Neural transmission. Supplementum 45, 177-185, 1995 | 7 | 1995 |
| Clinical outcomes of switching to insulin glargine 300 U/ml from other basal insulins in people with type 2 diabetes in Italy: a real-world study M Ragonese, M Larosa, S Angotti, S Annese, L Cruciani, M Dainelli, ... Diabetes Therapy 11, 2283-2298, 2020 | 5 | 2020 |
| Insulin and the future treatment of Alzheimer’s disease R Semprini, G Koch, L Belli, F D Lorenzo, M Ragonese, G Manenti, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2016 | 5 | 2016 |
| Ageing as a Trait de Union between diabetes and dementia for frailty R Semprini, M Ragonese, M Poggi, A Franze, A Martorana CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2013 | 4 | 2013 |
| Clinical profile of Alzheimer’s disease non-responder patient A Martorana, R Semprini, G Koch Advanced Understanding of Neurodegenerative Diseases, 156-168, 2011 | 4 | 2011 |
| N30 wave of somatosensory evoked potentials in Parkinson's disease: a pharmacological approach. R Traversa, M Pierantozzi, R Semprini, M Loberti, A Peppe, MC Cicardi, ... Electroencephalography and Clinical neurophysiology. Supplement 46, 193-200, 1996 | 2 | 1996 |
| A multicenter Italian randomised study on early treatment of Parkinson disease: comparison of 1-dopa, 1-deprenyl and dopaminoagonists. Study design and short term results Italian Parkinson Study Group, T Caraceni, M Musicco, M Gasparini, ... The Italian Journal of Neurological Sciences 13, 735-739, 1992 | 2 | 1992 |
| Clinical Outcomes of Switching to Insulin Glargine 300 U/ml from Other Basal Insulins in People with Type 2 Diabetes in Italy: A Real-World Study MRMLS Angotti, S Annese, LCMDG Lucisano, G Prosperini, ... | | 2020 |
